Abiopharma

🔍 Moriarty Thomas M (Executive)

Company: Albertsons Companies, Inc. (ACI)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 109,957 shares of Time-based Restricted Stock Units (Derivative)
  Date: 2026-04-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 109,957.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 36,653 shares of Performance-Based Restricted Stock Units (Derivative)
  Date: 2026-04-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 36,653.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 36,652 shares of Performance-Based Restricted Stock Units (Derivative)
  Date: 2026-04-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 36,562.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 36,652 shares of Performance-Based Restricted Stock Units (Derivative)
  Date: 2026-04-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 109,957.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: Each time-based restricted stock unit ("TBRSU") entitles the holder to one share of Class A common stock of Albertsons Companies, Inc. (the "Company"). The award vests in three equal installments on February 27, 2027, and February 26, 2028, and February 24, 2029, provided the reporting person remains continuously employed through each vesting date.
• F2: Each performance-based restricted stock unit ("PBRSU") award granted on April 16, 2026. Each PBRSU entitles the holder to one share of Class A common stock of the Company, vesting on February 24, 2029, contingent upon the achievement of performance goals for fiscal years 2026, 2027, and 2028, certification by the Compensation Committee, and the reporting person's continued service through the certification date. The reported number of PBRSUs is the "target" amount, with the actual number earned depending on performance goal attainment.